Advertisement

European Journal of Nuclear Medicine

, Volume 20, Issue 2, pp 170–172 | Cite as

Active removal of radioactivity in the blood circulation using biotin-bearing liposomes and avidin for rapid tumour imaging

  • Izumi Ogihara-Umeda
  • Toru Sasaki
  • Hideo Nishigori
Short Communication

Abstract

In order to shorten the delay between the administration of tumour-imaging agents and obtainment of scintigrams, rapid delivery of radionuclide to tumours followed by rapid clearance from the blood is required. We used liposomes with biotin bound on their surface (B-liposomes) as carriers for rapid delivery. For rapid blood clearance, we employed avidin in the expectation that the strong affinity between biotin and avidin would result in the aggregation of B-liposomes in the blood circulation, and that these aggregates would be taken up rapidly by the reticuloendothelial system, resulting in the rapid elimination of liposomes and the radionuclide encapsulated in them. When B-liposomes encapsulating gallium-67 deferoxamine were intravenously administered to mice bearing sarcoma 180, large amounts of 67Ga were delivered to tumours by 4 h after injection, though the 67Ga blood level remained high. On the other hand, administration of avidin 4 h after administration of the B-liposomes dramatically reduced the blood level so that it was only 5% of that in the non-treated group 1 h later. As a result, the tumour-to-blood ratio reached nearly 14 at 5 h after radionuclide administration, suggesting that rapid tumour-imaging will be feasible by means of this method.

Key words

Liposome Tumour imaging Avidin-biotin Blood clearance 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ogihara I, Kojima S, Jay M. Tumor uptake of 67Ga-carrying liposomes. Eur J Nucl Med 1986; 11: 405–411.Google Scholar
  2. 2.
    Ogihara-Umeda I, Kojima S. Increased delivery of gallium-67 to tumors using serum-stable liposomes. J Nucl Med 1988; 29:516–528.Google Scholar
  3. 3.
    Ogihara-Umeda I, Kojima S. Cholesterol enhances the delivery of liposome-encapsulated gallium-67 to tumors. Eur J Nucl Med 1989;15:612–617.Google Scholar
  4. 4.
    Ogihara-Umeda I, Sasaki T, Nishigori H. Development of a liposome-encapsulated radionuclide with preferential tumor accumulation — the choice of radionuclide and chelating ligand. Nucl Med Biol 1992; 19:753–757.Google Scholar
  5. 5.
    Green NM. The use of [14C]biotin for kinetic studies and for assay. Biochem J 1963; 89:585–591.Google Scholar
  6. 6.
    Hnatowich DJ, Virzi F, Rusckowski M. Investigations of avidin and biotin for imaging applications. J Nucl Med 1987; 28:1294–1302.Google Scholar
  7. 7.
    Bayer EA, Rivnay B, Skutelsky E. On the mode of liposome-cell interactions. Biotin-conjugated lipids as ultrastructural probes. Biochim Biophys Acta 1979; 550:464–473.Google Scholar
  8. 8.
    Hashimoto K, Loader JE, Kinsky SC. Iodoacetylated and biotinylated liposomes: effect of spacer length on sulfhydryl ligand binding and avidin precipitability. Biochim Biophys Acta 1986; 856:556–565.Google Scholar
  9. 9.
    Fiske CH, Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem 1925; 66:375–400.Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • Izumi Ogihara-Umeda
    • 1
  • Toru Sasaki
    • 2
  • Hideo Nishigori
    • 1
  1. 1.Faculty of Pharmaceutical SciencesTeikyo UniversitySagamiko, KanagawaJapan
  2. 2.Division of PET CenterTokyo Metropolitan Institute of GerontologyTokyoJapan

Personalised recommendations